Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00322790
First received: May 5, 2006
Last updated: April 2, 2015
Last verified: March 2015
  Purpose
Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females.

Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: INST 0549C Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study

Resource links provided by NLM:


Further study details as provided by New Mexico Cancer Care Alliance:

Enrollment: 0
Study Start Date: January 2006
Study Completion Date: September 2013
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Detailed Description:
Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals diagnosed with malignant germ cell tumors at University of New Mexico facilities
Criteria

Inclusion Criteria:

  • Survival for Malignant Germ Cell Tumors in Males and Females.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00322790

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87114
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico
  More Information

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00322790     History of Changes
Other Study ID Numbers: INST 0549C 
Study First Received: May 5, 2006
Last Updated: April 2, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on December 09, 2016